Pfizer starts testing anti-Covid pill for reduced infection risk
Share article:
Share article:

Pfizer starts testing anti-Covid pill for reduced infection risk

Credit: Jonas Roosens/ Belga

American pharmaceutical company Pfizer has announced it has started a large-scale clinical trial of its anti-Covid-19 pill to test how it reduces the risk of infection in people close to an infected person.

The antiviral will help prevent the virus from replicating and the approach of the medicine is “complementary” to the existing Covid-19 vaccine, according to Mikael Dolsten, Chief Scientific Officer of Pfizer’s Worldwide Research, Development and Medical.

“With the continued impact of COVID-19 around the world, we believe that tackling the virus will require effective treatments for people who contract, or have been exposed to, the virus, complementing the impact that vaccines have had in helping quell infections,” he said on Monday.

“If successful, we believe this therapy could help stop the virus early – before it has had a chance to replicate extensively – potentially preventing symptomatic disease in those who have been exposed and inhibiting the onset of infection in others,” Dolsten added.

He stressed the importance of preventing the virus from replicating in the battle to stop the continued evolution of new Covid-19 variants.

The medicine has two main benefits, as it can be given to people who already have the disease to lower the risk of them suffering severe symptoms, but it can also prevent those who have been in close contact from developing the virus.

Related News

 

The pill can be taken orally, meaning it can be used at the first sign of infection with, or exposure to, the virus, and should be administered in combination with a “low dose” of the drug ritonavir, which is used against the AIDS virus.

This particular phase of the trial will test the medicine on people who are at least 18 years old – up to 2,660 healthy adult participants will be enrolled – and who live in the same household as an individual with a confirmed symptomatic coronavirus infection.

Two other clinical trials have been underway since this summer on thousands of participants to assess the effectiveness of the product on people already infected with Covid-19, including a group of people at high risk of developing a severe case of the disease, and another at low risk.

Results from previous trials showed that the pill is not harmful to people’s health.

Latest news

More women take police selection tests in Belgium
The selection tests to become a police inspector have more and more female participants, according to figures released by Interior Affairs Minister ...
‘Absurd’: all Brussels schools should have the same Covid rules
Several city councillors for education in Brussels are calling to abolish the "absurd" differences in coronavirus measures for Dutch-speaking and ...
Massive renovations for iconic venue in the heart of Brussels
Brussels concert hall Ancienne Belgique has announced plans to renovate the AB Café and the AB Salon and is looking for a contractor fit for the job. ...
Display of child’s room in Brussels raises awareness of foster families
An exhibit that features a fictitious child’s bedroom has been on display since Tuesday at the Place d'Armes in Namur, with the support of the ...
Test results show pupils have fallen behind in Flemish schools
Learning delays have been reported in almost all subject areas in Flanders since the start of the pandemic, a trend that continued in 2021, a ...
Belgium considers relaxing testing rules for UK travellers
At the next Consultative Committee meeting, Belgium will look into relaxing the testing and entry policy for travellers coming from the United ...
Jette libraries start giving plants away with books
Visitors to libraries in the Brussels municipality of Jette will soon be able to pick up a free plant along with a book, thanks to the new Plantotek ...
‘Do what you want, but do it as safely as possible,’ experts warn
As the daily number of new coronavirus infections exceeds 3,000 for the first time since May, infectious disease expert Erika Vlieghe and ...
‘We’re running dry’: Brussels teacher shortage reaches critical levels
The teacher shortage in Brussels is affecting schools across language borders, according to Brussels’ Minister for Multilingualism and Dutch ...
New coronavirus infections above 3,000 for first time since May
The number of people testing positive for coronavirus has skyrocketed to the highest rate since the start of May 2021. Between 9 and 15 October, ...
Belgium in Brief: Getting To The Airport
When I saw the news of plans for a tram line and cycle path to connect Brussels' outskirts to the airport, my first reaction was sheer joy.  Let ...
EU should invest €5 trillion in climate plan, says State Secretary for Economic Recovery
The European Union must invest €5 trillion in its climate plan over the next decade to "retain its credibility as a political project," according ...